Article
[Outcomes of refractory or relapsed DNMT3A + cytogenetically normal acute myeloid leukemia patients followed the therapy including decitabine combined with CAG or CAG-like regimen].
Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi - 1 Dec 2015
Sun Yanjun, Xu Yang, Wu Depei, Shen Hongjie, Yang Zhen, Qiu Huiying, Chen Suning, Sun Aining
Abstract excerpt
OBJECTIVE: To study clinical characteristics of refractory or relapsed DNMT3A⁺ cytogenetically normal acute myeloid leukemia（CN-AML）patients, and to explore the overall response rate（ORR）and side effects of these patients followed the therapy including decitabine with CAG or CAGlike regimen. METHODS: In this study we retrospectively analyzed 53 refractory or relapsed CN- AML patients receiving the therapy...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.